Indication
Acute Myeloid Leukemia in Remission
2 clinical trials
2 products
1 drug
Clinical trial
Phase IB/II of CPX-351 as Maintenance Therapy in AML Patients Ineligible for Bone Marrow TransplantationStatus: Recruiting, Estimated PCD: 2024-08-01
Drug
CPX-351Clinical trial
Comparing Post-Transplant Cyclophosphamide With Calcineurin Inhibitors as A GVHD Prophylaxis to Standard Care of Methotrexate and Calcineurin Inhibitors for Acute Leukemia Incorporating Patient Pharmacogenomics ProfilingStatus: Recruiting, Estimated PCD: 2025-12-01
Product
CyclophosphamideProduct
Methotrexate